1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Drug Delivery Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Drug Delivery Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Drug Delivery Market Regional Analysis
6.2 Europe Drug Delivery Market Revenue 2021-2028 (US$ Million)
6.3 Europe Drug Delivery Market Forecast Analysis
7. Europe Drug Delivery Market Analysis – by Route of Administration
7.1 Injectable Drug Delivery
- 7.1.1 Overview
- 7.1.2 Injectable Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.2 Oral Drug Delivery
- 7.2.1 Overview
- 7.2.2 Oral Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.3 Transmucosal Drug Delivery
- 7.3.1 Overview
- 7.3.2 Transmucosal Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.4 Topical Drug Delivery
- 7.4.1 Overview
- 7.4.2 Topical Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.5 Implantable Drug Delivery
- 7.5.1 Overview
- 7.5.2 Implantable Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.6 Ocular Drug Delivery
- 7.6.1 Overview
- 7.6.2 Ocular Drug Delivery: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
8. Europe Drug Delivery Market Analysis – by Distribution Channel
8.1 Hospital Pharmacies
- 8.1.1 Overview
- 8.1.2 Hospital Pharmacies: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.2 Retail Pharmacies
- 8.2.1 Overview
- 8.2.2 Retail Pharmacies: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.3 Online Pharmacies
- 8.3.1 Overview
- 8.3.2 Online Pharmacies: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
9. Europe Drug Delivery Market Analysis – by End User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.2 Home Care Settings
- 9.2.1 Overview
- 9.2.2 Home Care Settings: Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.3 Other End User
- 9.3.1 Overview
- 9.3.2 Other End User : Europe Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
10. Europe Drug Delivery Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Drug Delivery Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 10.2.1.1 Europe Drug Delivery Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.1.2 UK: Europe Drug Delivery Market Breakdown, by Distribution Channel
- 10.2.1.1.3 UK: Europe Drug Delivery Market Breakdown, by End User
- 10.2.1.2 Germany:
Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.2.2 Germany: Europe Drug Delivery Market Breakdown, by Distribution Channel
- 10.2.1.2.3 Germany: Europe Drug Delivery Market Breakdown, by End User
- 10.2.1.3 France:
Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.3.2 France: Europe Drug Delivery Market Breakdown, by Distribution Channel
- 10.2.1.3.3 France: Europe Drug Delivery Market Breakdown, by End User
- 10.2.1.4 Russia:
Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.4.2 Russia: Europe Drug Delivery Market Breakdown, by Distribution Channel
- 10.2.1.4.3 Russia: Europe Drug Delivery Market Breakdown, by End User
- 10.2.1.5 Italy:
Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.5.2 Italy: Europe Drug Delivery Market Breakdown, by Distribution Channel
- 10.2.1.5.3 Italy: Europe Drug Delivery Market Breakdown, by End User
- 10.2.1.6 Rest of Europe:
Europe Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.6.2 Rest of Europe: Europe Drug Delivery Market Breakdown, by Distribution Channel
- 10.2.1.6.3 Rest of Europe: Europe Drug Delivery Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Bausch Health Companies Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Baxter International Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Becton Dickinson and Co
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Boehringer Ingelheim International GmbH
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Boston Scientific Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Gerresheimer AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 GlaxoSmithKline Plc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Johnson & Johnson
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Novartis AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Novo Nordisk AS
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Pfizer Inc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Sever Pharma Solutions
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations